The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients | Zendy

Huijuan Li | Zendy; Yangyang Xu | Zendy; Bing Wan | Zendy; Yong Song | Zendy; Ping Zhan | Zendy; Yangbo Hu | Zendy; Qun Zhang | Zendy; Fang Zhang | Zendy; Hongbing Liu | Zendy; Tianhong Li | Zendy; Haruhiko Sugimura | Zendy; Federico Cappuzzo | Zendy; Lin Dang | Zendy; Tangfeng Lv | Zendy

Open Access

The clinicopathological and prognostic significance of PD-L1 expression assessed by immunohistochemistry in lung cancer: a meta-analysis of 50 studies with 11,383 patients

Author(s) -

Huijuan Li,

Yangyang Xu,

Bing Wan,

Yong Song,

Ping Zhan,

Yangbo Hu,

Qun Zhang,

Fang Zhang,

Hongbing Liu,

Tianhong Li,

Haruhiko Sugimura,

Federico Cappuzzo,

Lin Dang,

Tangfeng Lv

Publication year - 2019

Publication title -

translational lung cancer research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.474

H-Index - 41

eISSN - 2226-4477

pISSN - 2218-6751

DOI - 10.21037/tlcr.2019.08.04

Subject(s) - medicine , meta analysis , immunohistochemistry , hazard ratio , lung cancer , confidence interval , subgroup analysis , odds ratio , oncology , stage (stratigraphy) , gastroenterology , pathology , paleontology , biology

We conducted a meta-analysis to systematically evaluate the relationship between programmed death-ligand 1 (PD-L1) expression and survival in patients with lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research